| Schedule of Segment Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
|
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
Three Months Ended March 31, 2024 |
|
Sales |
|
Development |
|
Consolidated |
Net revenue |
|
$ |
13,030 |
|
$ |
— |
|
$ |
13,030 |
Cost of goods - product revenue |
|
|
(6,816) |
|
|
— |
|
|
(6,816) |
Research and development |
|
|
(7,884) |
|
|
(16,955) |
|
|
(24,839) |
Selling, general and administrative |
|
|
(8,420) |
|
|
(9,521) |
|
|
(17,941) |
Other expense |
|
|
(352) |
|
|
(2,105) |
|
|
(2,457) |
Segment loss |
|
$ |
(10,442) |
|
$ |
(28,581) |
|
$ |
(39,023) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
|
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
Three Months Ended March 31, 2023 |
|
Sales |
|
Development |
|
Consolidated |
Net revenue |
|
$ |
12,213 |
|
$ |
216 |
|
$ |
12,429 |
Cost of goods - product revenue |
|
|
(6,449) |
|
|
— |
|
|
(6,449) |
Research and development |
|
|
(2,033) |
|
|
(37,473) |
|
|
(39,506) |
Selling, general and administrative |
|
|
(13,291) |
|
|
(12,050) |
|
|
(25,341) |
Other expense |
|
|
(575) |
|
|
4,297 |
|
|
3,722 |
Segment loss |
|
$ |
(10,135) |
|
$ |
(45,010) |
|
$ |
(55,145) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
($ in thousands) |
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
March 31, 2024 |
|
Sales |
|
Development |
|
Total Assets |
Intangible assets, net |
|
$ |
19,473 |
|
$ |
— |
|
$ |
19,473 |
Tangible assets |
|
|
47,098 |
|
|
98,074 |
|
|
145,172 |
Total segment assets |
|
$ |
66,571 |
|
$ |
98,074 |
|
$ |
164,645 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
($ in thousands) |
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
December 31, 2023 |
|
Sales |
|
Development |
|
Total Assets |
Intangible assets, net |
|
$ |
20,287 |
|
$ |
— |
|
$ |
20,287 |
Tangible assets |
|
|
56,561 |
|
|
90,678 |
|
|
147,239 |
Total segment assets |
|
$ |
76,848 |
|
$ |
90,678 |
|
$ |
167,526 |
|